HomeBIOTECHNOLOGY
BIOTECHNOLOGY
Medical Device News Magazine reports breaking biotechnology news in addition to medical device news.
Vivera Pharmaceuticals Announces a New Diagnostic Test Solution For COVID-19
Access to reliable testing allows for better patient management and more informed public health decisions. By utilizing OmeCare's dedicated CLIA-certified and CAP-accredited facility, Vivera and OmeCare are helping to eliminate excessive wait times.
NeuroSense Therapeutics Announces Encouraging Interim Results of Clinical Study in ALS
The study, containing 15 patients, is scheduled to continue for an additional 6 months.
SQI Diagnostics Expanding Its Proprietary Rapid Diagnostic Testing Portfolio Targeting Organ Transplant, Autoimmune Disease and Serological Testing
SQI Diagnostics, Inc. CEO Mr. Robert L. Chioini stated, “Within our organ transplant, autoimmune disease, and serological testing business units we have multiple products in clinical development, and we believe these advanced tests have the potential to offer patients and consumers significant benefit once they receive regulatory approval.
Enesi Pharma to Develop Thermostable, Solid Dose DNA Vaccine Targeting Zika Virus under New Partnership with The University of Adelaide
Enesi Pharma to Develop Thermostable, Solid Dose DNA Vaccine Targeting Zika Virus under New Partnership with The University of Adelaide
Oncimmune Holdings Reports Autoantibody Profiling Program Agreement Signed with ImmunoINSIGHTS, World-Leading BioPharm Company
Oncimmune CEO dam M Hill said: "We are pleased to announce this partnership between our ImmunoINSIGHTS business and another world-leading biopharmaceutical company."
Micron Biomedical Progresses with Clinical Evaluation of Its Technology for Measles-Rubella Vaccination
Micron Biomedical reports their applicator-free technology is well-suited for the administration of vaccines and, in particular, for measles-rubella vaccination in low- and middle-income countries.
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ImmunoGen, Inc. is a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer.
Relation Therapeutics Teams Up with Mila in Coalition to Identify COVID-19 Therapeutic Candidates
Project RE will focus on finding therapies to tackle viral entry and replication and is co-led between Mila (Quebec AI Institute) and Relation Therapeutics, with the overall scientific direction by Mila founder Professor Yoshua Bengio.
National Science Foundation Awards Vitanova Biomedical a $225,000 Grant: Funds Allow for Research and Development on the Company’s Light-Activated Intracellular Acidosis
Vitanova Biomedical is developing a prostate-specific membrane antigen targeted drug, VNBp-1, formulated as a first line treatment for local stage prostate cancer.